CA1248096A - Optionally n-substituted aminodesoxy-1,4;3.6- dianhydrohexitol derivatives, processes for their preparation and their use - Google Patents

Optionally n-substituted aminodesoxy-1,4;3.6- dianhydrohexitol derivatives, processes for their preparation and their use

Info

Publication number
CA1248096A
CA1248096A CA000381304A CA381304A CA1248096A CA 1248096 A CA1248096 A CA 1248096A CA 000381304 A CA000381304 A CA 000381304A CA 381304 A CA381304 A CA 381304A CA 1248096 A CA1248096 A CA 1248096A
Authority
CA
Canada
Prior art keywords
dianhydro
desoxy
iditol
glucitol
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000381304A
Other languages
English (en)
French (fr)
Inventor
Klaus Klessing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Willmar Schwabe GmbH and Co KG
Original Assignee
Dr Willmar Schwabe GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Willmar Schwabe GmbH and Co KG filed Critical Dr Willmar Schwabe GmbH and Co KG
Application granted granted Critical
Publication of CA1248096A publication Critical patent/CA1248096A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
CA000381304A 1980-07-25 1981-07-08 Optionally n-substituted aminodesoxy-1,4;3.6- dianhydrohexitol derivatives, processes for their preparation and their use Expired CA1248096A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3028288.3 1980-07-25
DE19803028288 DE3028288A1 (de) 1980-07-25 1980-07-25 Gegebenenfalls n-substituierte aminodesoxy-1.4;3.6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und deren verwendung

Publications (1)

Publication Number Publication Date
CA1248096A true CA1248096A (en) 1989-01-03

Family

ID=6108128

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000381304A Expired CA1248096A (en) 1980-07-25 1981-07-08 Optionally n-substituted aminodesoxy-1,4;3.6- dianhydrohexitol derivatives, processes for their preparation and their use

Country Status (7)

Country Link
US (2) US4413122A (ja)
EP (1) EP0044932B1 (ja)
JP (1) JPS5764696A (ja)
AT (1) ATE12499T1 (ja)
CA (1) CA1248096A (ja)
DE (1) DE3028288A1 (ja)
ES (1) ES503997A0 (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3028272A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte alkylamino-desoxy-1.4;3.6-dianhydro-hexit-nitrate, verfahren zu ihrer herstellung und pharmazeutische zubereitung
DE3421072A1 (de) * 1984-06-06 1985-12-12 Heinrich Mack Nachf., 7918 Illertissen 1,4:3,6-dianhydro-hexit-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2014520C (en) * 1989-04-17 1996-07-16 Fumio Suzuki Hexitol derivatives
ATE176668T1 (de) 1993-07-23 1999-02-15 Merrell Pharma Inc Neue 9-n-bicyclische nucleosidverbindungen nützlich als selektive inhibitoren von proinflammatorische cytokinen
US6994310B2 (en) * 2003-04-24 2006-02-07 Ranco Incorporated Of Delaware Stepper motor driven valve for thermal management and associated method of use
DE102009000592A1 (de) 2009-02-04 2010-08-05 Evonik Degussa Gmbh Verfahren zur Herstellung von Aminogruppen tragenden, multizyklischen Ringsystemen
KR102638391B1 (ko) 2023-05-30 2024-02-20 삼화페인트공업주식회사 다이알칸설포닐 아이소소바이드 화합물의 제조 방법, 리튬이차전지용 전해액 첨가제, 리튬이차전지용 전해액 및 리튬이차전지

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1545635A1 (de) * 1965-10-16 1969-08-07 Boehringer Mannheim Gmbh Verfahren zur Herstellung von Adenosin-Derivaten
GB1356374A (en) * 1971-04-29 1974-06-12 American Home Prod Mononitrate esters of 1,3 3,6-dianhydro-d-glucitol
US3886186A (en) * 1971-04-29 1975-05-27 American Home Prod Mononitrate esters of 1,4:3,6-dianhydro-d-glucitol
DE3028273A1 (de) * 1980-07-25 1982-02-25 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Durch purinbasen substituierte 1.4;3.6-dianhydro-hexit-nitrate

Also Published As

Publication number Publication date
ES8403902A1 (es) 1984-04-16
ES503997A0 (es) 1984-04-16
US4413122A (en) 1983-11-01
US4535158A (en) 1985-08-13
JPS637550B2 (ja) 1988-02-17
EP0044932A1 (de) 1982-02-03
DE3028288C2 (ja) 1991-10-10
EP0044932B1 (de) 1985-04-03
ATE12499T1 (de) 1985-04-15
DE3028288A1 (de) 1982-02-25
JPS5764696A (en) 1982-04-19

Similar Documents

Publication Publication Date Title
US4923872A (en) Analogues of pyrrolo[3,2d]pyrimidin-4-ones
US4622324A (en) 1.4;3.6-Dianhydrohexitol nitrates substituted by purine bases, and pharmaceutical compositions
CA1244411A (en) Aminodesoxy-1.4;3.6-dianhydrohexitol nitrates, processes for their preparation and pharmaceutical composition
CA1248096A (en) Optionally n-substituted aminodesoxy-1,4;3.6- dianhydrohexitol derivatives, processes for their preparation and their use
FI85856C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva pyrrolo/3,2-d/pyrimidinoner.
WO2008027585A2 (en) Pyrrolo[3,2-d]pyrimidines that are selective antagonists of a2b adenosine receptors
US5002950A (en) 7-deazaguanines as immunomodulators
US4921858A (en) 7-deazaguanines as immunomodulators
CA1294960C (en) 7-deazaguanines as immunomodulators
Pickering et al. The synthesis of 4′-t-butylcarbamyl-and 4′-p-Toluenesulphonamidyl-2′, 3′-dideoxy pyrimidine nucleoside analogues
US4542137A (en) Alkylaminodesoxy-1.4;3.6-dianhydrohexitol nitrates substituted by purine bases and pharmaceutical compositions
EP0072977A1 (en) Process for the production of 2-beta-D-ribofuranosylthiazole-4-carboxamide
WO2000006573A1 (en) Antiviral alkyl substituted purine derivatives and their preparation
EP0234494B1 (en) Isohexide nucleosides, processes for their preparation and their use as medicaments
US5281708A (en) 9-Substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors of PNP
EP0289992B1 (en) Process for preparing purine derivates
EP0290885A2 (en) 1,4:3,6-Dianhydrosorbitol 2-mono-nitrate and 5-mononitrate esters, a process for the preparation thereof and pharmaceutical compositions therefrom
EP3498715B1 (en) Anti-hcmv virus compound
WO2016207194A1 (en) Synthesis of phosphoramidates
SU1757467A3 (ru) Способ получени дезокциацикловира
US5098905A (en) 7-deazaguanines as immunomodulators
US6160131A (en) Scalable method for the isolation of anti-HIV agents from the tropical plant calophyllum
Stoelting et al. The synthesis and properties of new carbohydrate‐modified mesoionic thiazolo [3, 2‐α] pyrimidine‐5, 7‐dione acyclonucleosides
US4996319A (en) -2-Amino-4,6-dichloro-5-(2-cyanomethyl-2-amino-5(cyanomethyl)-4,6-dichloro pyrimidine
KR880000764B1 (ko) 9-(2-하이드록시 에톡시메틸)구아닌의 제조방법

Legal Events

Date Code Title Description
MKEX Expiry